Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Cardiac Mapping Market In 2029?

In recent years, there has been a significant growth in the cardiac mapping market. The market, which was worth $2.3 billion in 2024, is predicted to rise to $2.48 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. Factors contributing to the growth during the historic period include the inception of catheter ablation, advances in 3D mapping systems, enhancements in imaging technologies, an increase in occurrences of cardiac arrhythmias, and a surge in minimally invasive procedures.

What Growth Rate Is Forecasted for the Cardiac Mapping Market by 2029?

The market for cardiac mapping is anticipated to exhibit substantial growth in the forthcoming years with a projected reach of $3.29 billion by 2029, reflecting a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this rising trend during the forecast period include an increase in cardiovascular diseases, an aging population, heightened awareness and screening initiatives, advancements in healthcare infrastructure, and a rise in health-related problems. Key trends during this period are expected to be the integration of artificial intelligence (AI), the development of real-time 3D mapping systems, the advancement in catheter technologies, the shift towards cloud-based data analysis, and improvements in electrophysiology software.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16643&type=smp

Which Key Companies Are Shaping the Future of the Cardiac Mapping Market?

Major companies operating in the cardiac mapping market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., GE Healthcare Technologies, Boston Scientific Corporation, Epmap-System, APN Health LLC, BIOTRONIK SE & Co. KG, Lepu Medical  Technology Co. Ltd., MicroPort Scientific Corporation, Biosense Webster Inc., BioSig Technologies Inc., CardioFocus Inc., Kardium Inc., Acutus Medical Inc., Navix Medical Ltd., EP Solutions SA, CoreMap Inc., Catheter Precision Inc.

Which Factors Are Driving Demand in the Cardiac Mapping Industry?

The rise in heart diseases is anticipated to fuel the expansion of the cardiac mapping market in the future. Heart diseases encompass various ailments that damage the heart’s formation and function, resulting in issues like arrhythmias, heart attacks, and heart failure. The increment in heart disease cases can be traced back to factors like inactive lifestyles, unhealthy eating habits, and elderly populations. Cardiac mapping serves to detect and remedy heart diseases by accurately pinpointing the heart’s rhythm abnormalities. For example, as per the British Heart Foundation, a cardiovascular research charity in the UK, it’s projected that over a million people in the UK are struggling with heart failure in January 2024. Each year, about 200,000 fresh cases of heart failure are identified, with nearly 730,000 individuals included in their GP’s heart failure register. Hence, the high occurrence of heart diseases is contributing to the growth of the cardiac mapping market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=16643&type=smp

How Is the Cardiac Mapping Market Segmented by Several Divisions?

The cardiac mapping market covered in this report is segmented –

1) By Type: Contact Cardiac Mapping Systems, Non-Contact Cardiac Mapping Systems

2) By Indications: Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Other Indications

3) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users

Subsegments:

1) By Contact Cardiac Mapping Systems: Electrode-Based Mapping Systems, Catheter-Based Mapping Systems, Integrated Mapping And Ablation Systems, 3D Mapping Systems

2) By Non-Contact Cardiac Mapping Systems: Non-Contact Voltage Mapping Systems, Electrocardiographic Mapping Systems, Optical Mapping Systems, Magnetic Field Mapping Systems

What are the Emerging Market Trends Driving the Growth of the Cardiac Mapping Industry?

Leading firms in the cardiac mapping market are creating innovative solutions like cardiac mapping platforms to improve the precision in diagnosis and effectiveness of treatments. These platforms are sophisticated technologies that assist in visualizing and examining the electrical activity in the heart, which is beneficial in diagnosing and treating cardiac arrhythmias and other heart ailments. For example, in January 2022, the US healthcare firm, Abbott Laboratories, secured FDA 510(k) approval for their EnSite X EP system, a cardiac mapping platform aimed at aiding doctors in pinpointing the source of unusual heart rhythms. This system generates comprehensive 3D heart maps, providing a full 360-degree view, irrespective of catheter positioning. This is enabled through Abbott’s unique EnSite omnipolar technology (OT), using the advisor HD grid catheter to deliver accurate electrograms from any catheter position.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cardiac-mapping-global-market-report

Which Regions Are Driving Growth in the Cardiac Mapping Market?

North America was the largest region in the cardiac mapping market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac mapping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16643

This Report Delivers Insight On:

1. How big is the cardiac mapping market, and how is it changing globally?

2. Who are the major companies in the cardiac mapping market, and how are they performing?

3. What are the key opportunities and risks in the cardiac mapping market right now?

4. Which products or customer segments are growing the most in the cardiac mapping market?

5. What factors are helping or slowing down the growth of the cardiac mapping market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.